Title: How to Tell the President Or At Least the Secretary of HHS The Facts About Ephedra
1How to Tell the PresidentOr At Least the
Secretary of HHSThe Facts About Ephedra
Sally C. Morton, RAND Statistics Group
Shekelle PG, Hardy ML, Morton SC, Maglione M,
Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L,
Gagné J. Efficacy and safety of ephedra and
ephedrine for weight loss and athletic
performance. A meta-analysis. JAMA.
2003289(12)1537-1545.
Southern California Evidence-Based Practice
Center
2Ephedra Use in the United States
- Ephedra is an herbal dietary supplement regulated
under the Dietary Supplement Health and Education
Act of 1994 (DSHEA) - Specifically forbids FDA to regulate
- Forbids disease treatment claims
- Places burden of proof for safety on the
government - Ephedra is sold as part of many concoctions
- Metabolife 356
- Natures Nutrition Formula 1
- Ripped Fuel (Twin Labs), Eola, Slacker II
- Ephedra industry claims 3 billion servings are
sold per year
3Ephedra Clinical Efficacy and Side Effects
Project
- Systematic review project conducted at the AHRQ
Southern California Evidence-Based Practice
Center - Conduct comprehensive literature search,
including unpublished and non-English literature - Conduct meta-analysis of clinical trial data as
appropriate to assess efficacy of ephedra for
weight loss and improved athletic performance - Examine safety using data from clinical trials,
published case reports, and FDA and Metabolife
adverse event databases
4Our Project Had Started in 2001
- June 2002
- Public Citizen asks HHS Secretary to ban ephedra
as a threat to public health - HHS Secretary Thompson announces that RAND will
conduct a comprehensive review of the existing
science on ephedrine alkaloids - August 2002
- Ephedra is an imminent hazard Senator
Durbin - October 2002
- The results of the RAND review will help FDA's
scientists to develop future
regulatory actions on dietary supplements
containing ephedrine alkaloids.
FDA Acting Commissioner Crawford
5(No Transcript)
6The Anecdotal Adverse Event
- Baltimore Orioles pitcher Steve Bechler dies on
February 17, 2003 - Ephedra is implicated
- "This was certainly a preventable death it
didn't have to occur, this kind of tragedy," said
Broward County's chief medical examiner (CBS News
2/18/03).
7Conclusions Of Our Evidence Report Released
2/28/03
- Ephedra does promote short-term weight loss but
long-term effects are unknown - Ephedrine plus caffeine does have modest
short-term effects on athletic performance - Ephedra does cause some side effects such as
palpitations and psychiatric symptoms (source
clinical trial data) - The sentinel events (e.g., 5 deaths, 5 heart
attacks, 11 strokes) we identified are a signal
that ephedra may cause serious adverse events,
and this effect is biologically plausible
(source adverse event case report files)
8Limitations of the Analysis
- Clinical trials
- Usual limitations for clinical trial
meta-analysis - No deaths or other serious adverse events
reported but insufficient sample size to detect a
rate of adverse events smaller than 1 per 1000 - Case reports
- Did not have access to all reports
- Many reports did not contain sufficient
documentation - No estimate of the number of people using ephedra
- Study design considered insufficient to warrant
conclusions regarding causality - Definitive case-control study needed to assess
safety
9Federal Government Response (2/28/03)
- HHS Acts to Reduce Potential Risks of Dietary
Supplements Containing Ephedra, FDA News - Ban on advertising effects of ephedra on athletic
performance - Proposed new warning label for ephedra
- HHS Secretary Thompson says "We want to caution
all Americans - particularly athletes and those
who engage in strenuous activities - about using
dietary supplements that contain ephedra. There
continue to be serious questions about the risks
surrounding this particular dietary supplement." - Congressional Hearings 7/23-24/03 FDA
Commissioner McClellan says A ban on ephedra use
is in the range of options we are considering."
10Ephedra Education Council (3/12/03)
- The Rand report confirms that more than 55
clinical studies support the safety and benefits
of the Ephedra/caffeine combination, when taken
as directed by overweight, but otherwise healthy
individuals. Recently announced efforts by the
Food and Drug Administration (FDA) to regulate
Ephedra should consider these studies in the
agency's final rulemaking decision. Furthermore,
FDA should also ban irresponsible marketing
practices, a complete ban on use by minors,
mandatory strict science-based serving
recommendations and medical condition warnings
for the labels of all Ephedra products. - The Ephedra industry continues to call upon the
Food and Drug Administration to adopt
science-based regulations for Ephedra dietary
supplement products. The industry is committed to
working with FDA on appropriate measures that
guarantee continued access for the millions of
responsible adult Americans who consume these
products every day for safe and effective weight
loss." -
11How to Tell The Facts
- Focus on a small number of conclusions and
support with strong analyses - Promotes short-term weight loss, no long term
studies, very limited evidence on athletic
performance - Does cause some side effects
- Sentinel events are a serious signal but further
research needed to establish causality
12How to Tell The Facts
- Anticipate
- Who will focus on which conclusions
- The spins from different audiences and in
multiple directions - When you speak to journalists, politicians are
listening - Beware yet accept better yet use
the anecdote